CDMO Services

One partner, molecule to market.

Development, manufacture and distribution under a single quality system, so a programme does not change hands at every stage.

What we run

Four service lines.

Cell line and process development

Candidate to a locked, characterised process, with the analytics that prove comparability.

Clinical manufacture

GMP supply for trials, with the batch documentation regulators expect on file from day one.

Commercial supply

Validated lines that reproduce a process batch after batch, at national volume.

Distribution and cold chain

Monitored 2 to 8 degrees C distribution with per-pallet telemetry and excursion handling.

How an engagement runs

Four stages, one owner.

01
Assess
Feasibility, gap analysis and a costed plan.
02
Transfer
Process and analytics moved onto the platform.
03
Validate
Process performance qualification and release testing.
04
Supply
Commercial manufacture and lifecycle support.
What partners say

From the people who run the programmes.

The handover we were dreading never happened. The same team that developed the process ran the validation batches.
Programme DirectorBiosimilarsRegional health system (demo)
Their analytics package was the reason our dossier cleared first pass. Comparability was settled before we filed.
Head of RegulatoryFiling strategySpecialty manufacturer (demo)
Capacity was reserved, not promised. That distinction is the whole relationship.
Supply Chain LeadProcurementNational tender body (demo)

Bring us a molecule.

Send a target product profile and a market. We will come back with a costed route.